Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Retina. 2015 Jul;35(7):1303–1314. doi: 10.1097/IAE.0000000000000483

Table 5A.

Treatment status after Positive Fluid Discrepancy (PFD) event.

Treatment Status at Subsequent Visit after PFD Event All Treatment
PFD Events
n (%)

Not treated 779 (54.0)

Treated for macular fluid on OCT only 520 (36.0)
Treated for macular fluid on OCT and another reason 99 (6.9)

Treated for persistent subretinal hemorrhage or new hemorrhage 14 (1.0)
Treated for leakage on fluorescein angiography 3 (0.2)
Treated for decreased visual acuity only 17 (1.2)
Multiple non-OCT reasons 5 (0.3)
Other 6 (0.4)

Total 1443* (100.0)

PFD= Positive Fluid Discrepancy: RC identified macular fluid on OCT and the ophthalmologist did not administer treatment at the corresponding visit when there were no contraindications to treatment. Macular fluid = presence of one or more of the following on OCT: intraretinal fluid, subretinal fluid, and sub-retinal pigment epithelium (RPE) fluid.

*

155 eyes that did not have subsequent visit after positive fluid discrepancy were excluded.